Contract title - cancer prevention agent development program: early phase clinical research
Ended Awarded Last action
- Contract number
- 75N91019F00130
- Awardee
-
Northwestern University UEI KG76WYENL5K1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,031,556
Award facts
- Opportunity
-
- TORFPNN2019 Solicitation number
- Contract value 100% obligated
- $2,031,555.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Evanston, IL 60208, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$154,190 | |
| Funding Only Action | $115,813 | |
| Supplemental Agreement for work within scope | -$89,794 | |
| Exercise an Option | $73,029 | |
| Exercise an Option | $384,492 | |
| Exercise an Option | $426,812 | |
| Exercise an Option | $637,416 | |
| Other Administrative Action | $0 | |
| Original award | $637,977 |
About this award
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Northwestern University. The contract is titled "CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH" and is a delivery order under the "Cancer Prevention Agent Development Program 2012-2017" indefinite delivery vehicle (IDV). The contract has a ceiling value of $2,031,555.74 and a period of performance ending on September 22, 2024. The contract does not have a set-aside designation. This award supports Northwestern University's research and development efforts related to early-phase clinical trials for cancer prevention agents. As a leading research institution, Northwestern University has a history of collaborating with federal agencies, including the Department of Veterans Affairs, to provide consulting, technical, and research services across various disciplines.
Quick answers
Who was awarded contract 75N91019F00130?
75N91019F00130 was awarded to Northwestern University by National Cancer Institute (National Institutes of Health) on September 23, 2019.
How much is contract 75N91019F00130 worth?
The government has obligated $2,031,556 on 75N91019F00130.
Is contract 75N91019F00130 an order under another contract?
Yes. 75N91019F00130 is a delivery order under HHSN261201200035I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.
Was contract 75N91019F00130 competed?
The extent of competition for 75N91019F00130 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award